Short Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Drops By 84.8%

Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) was the recipient of a significant decline in short interest during the month of July. As of July 15th, there was short interest totaling 17,399 shares, a decline of 84.8% from the June 30th total of 114,234 shares. Based on an average trading volume of 41,300 shares, the short-interest ratio is presently 0.4 days. Approximately 1.2% of the shares of the company are sold short.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. IFP Advisors Inc increased its position in Global X Genomics & Biotechnology ETF by 20.8% during the third quarter. IFP Advisors Inc now owns 2,835 shares of the company’s stock worth $110,000 after buying an additional 489 shares during the period. Smartleaf Asset Management LLC boosted its holdings in shares of Global X Genomics & Biotechnology ETF by 30.9% in the second quarter. Smartleaf Asset Management LLC now owns 19,548 shares of the company’s stock valued at $164,000 after acquiring an additional 4,615 shares during the period. Sei Investments Co. grew its position in shares of Global X Genomics & Biotechnology ETF by 110.4% during the second quarter. Sei Investments Co. now owns 23,073 shares of the company’s stock worth $194,000 after acquiring an additional 12,105 shares during the last quarter. Wealth Management Partners LLC purchased a new position in shares of Global X Genomics & Biotechnology ETF during the first quarter worth approximately $244,000. Finally, Creative Financial Designs Inc. ADV grew its position in shares of Global X Genomics & Biotechnology ETF by 4.1% during the fourth quarter. Creative Financial Designs Inc. ADV now owns 12,124 shares of the company’s stock worth $551,000 after acquiring an additional 481 shares during the last quarter. Hedge funds and other institutional investors own 56.95% of the company’s stock.

Global X Genomics & Biotechnology ETF Stock Performance

NASDAQ GNOM traded down $0.98 during trading hours on Friday, hitting $53.92. The company had a trading volume of 13,696 shares, compared to its average volume of 15,486. The business has a 50 day moving average of $52.16 and a 200-day moving average of $48.19. The company has a market cap of $78.72 million, a PE ratio of -23.04 and a beta of 1.16. Global X Genomics & Biotechnology ETF has a 1-year low of $34.04 and a 1-year high of $59.48.

Global X Genomics & Biotechnology ETF Dividend Announcement

The company also recently announced a dividend, which was paid on Tuesday, July 7th. Stockholders of record on Monday, June 29th were issued a $0.0579 dividend. The ex-dividend date of this dividend was Monday, June 29th. Global X Genomics & Biotechnology ETF’s payout ratio is presently -27.35%.

Global X Genomics & Biotechnology ETF Company Profile

Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center.